Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Clinical trial NCT00580333 · COMPLETED
Trial details
- NCT number
- NCT00580333
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-12-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.